Citadel Advisors
SYRA

Citadel Advisors’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

Citadel Advisors’s Portfolio SYRA Stock Details SYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,109
Closed -$9.67K – 15901
2024
Q4 		$9.67K Sell
24,109
-36,113
-60% -$14.5K ﹤0.01% 13635
2024
Q3 		$25.5K Buy
+60,222
New +$63.9K ﹤0.01% 12580

Other funds holding SYRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's SYRA Position: Q1 2025 in Review

Citadel Advisors sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q1 2025, closing a stake of 24,109 shares — an estimated $9.67K sold.

Citadel Advisors first reported a position in SYRA in Q3 2024 and held it in 2 quarters. The position peaked at $25.5K in Q3 2024. 9 funds tracked by Wall St. Rank hold SYRA as of Q1 2025.

  • Citadel Advisors reported no remaining Syra Health Corp. Class A Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 24,109 Syra Health Corp. Class A Common Stock shares in Q1 2025, an estimated $9.67K.
  • Citadel Advisors first reported a position in Syra Health Corp. Class A Common Stock in Q3 2024 and held it in 2 quarters.
  • Citadel Advisors's Syra Health Corp. Class A Common Stock position peaked at $25.5K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.